Loading clinical trials...
Loading clinical trials...
Phase II Study of Faslodex ? in Recurrent/Metastatic Endometrial Carcinoma
Conditions
Interventions
Fulvestrant
Start Date
August 30, 2004
Primary Completion Date
March 17, 2008
Last Updated
March 20, 2019
NCT05334069
NCT02684227
NCT01199250
NCT01164735
NCT02996825
NCT00027690
Lead Sponsor
Gynecologic Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions